Adverse events68

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 68

Type	Event	Organ system	Group	Affected	At risk
other	Nausea	Gastrointestinal disorders	Placebo	5	83
other	Nausea	Gastrointestinal disorders	Omalizumab 300 mg	15	252
other	Diarrhoea	Gastrointestinal disorders	Placebo	5	83
other	Diarrhoea	Gastrointestinal disorders	Omalizumab 300 mg	13	252
other	Sinusitis	Infections and infestations	Placebo	9	83
other	Sinusitis	Infections and infestations	Omalizumab 300 mg	31	252
other	Nasopharyngitis	Infections and infestations	Placebo	8	83
other	Nasopharyngitis	Infections and infestations	Omalizumab 300 mg	30	252
other	Upper respiratory tract infection	Infections and infestations	Placebo	4	83
other	Upper respiratory tract infection	Infections and infestations	Omalizumab 300 mg	29	252
other	Urinary tract infection	Infections and infestations	Placebo	1	83
other	Urinary tract infection	Infections and infestations	Omalizumab 300 mg	15	252
other	Headache	Nervous system disorders	Placebo	6	83
other	Headache	Nervous system disorders	Omalizumab 300 mg	27	252
other	Oropharyngeal pain	Respiratory, thoracic and mediastinal disorders	Placebo	7	83
other	Oropharyngeal pain	Respiratory, thoracic and mediastinal disorders	Omalizumab 300 mg	11	252
other	Sinus congestion	Respiratory, thoracic and mediastinal disorders	Placebo	5	83
other	Sinus congestion	Respiratory, thoracic and mediastinal disorders	Omalizumab 300 mg	3	252
other	Idiopathic urticaria	Skin and subcutaneous tissue disorders	Placebo	10	83
other	Idiopathic urticaria	Skin and subcutaneous tissue disorders	Omalizumab 300 mg	37	252

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01264939/events